Managed Care

Quote

Anonymous

Guest
Do we really need them? Seems like everything is handed to the payers on a silver platter - no work involved. Dossiers are completed, with the little bit of incentives we offer there is no negotiation needed and our medical team rocks which does not require acct mgmt involvement.

And when i do need their expertise, they dont understand what is happening in specialty pharmacy and are clueless with the PA process.

Lets get rid of these x-pfizer cast-aways.
 


















The HEPc Sales Team = hired guns. Shallow understanding of business. No real desire to understand. Running around making noise. This is by design. And, it's working. The perfect approach for this class, and this drug. No focus on quality. No need. Just quantity, and noise level. Keep drug name in front of prescriber longer than competition. Keep up the noise level, ride the ship for as long as you can, and then eventually look for a new ship. Mid-short term business approach.

The CF Sales Team is skilled. Clinically sound professionals. Understand the business extremely well within therapeutic area. Know customers well. Understand or seek to understand customer needs. Clinical requirements, resource allocation, reimursement issues, etc. Long-term business approach.

Excellent approach by both Marketing teams. Spot on. Keep up the good work. Drive the share price.
 












Anonymous said:
Did I not tell you back in September?
Click to expand...

Quote:
Originally Posted by Anonymous View Post
"Idenix remains focused on the discovery and development of nucleotides and continues its program to identify new compounds and evaluate multiple candidates for development from this discovery program. The nucleoside discovery capability can also be applied to other therapeutic areas outside of HCV, and the Company looks forward to exploring new indications."


Cancer-Cancer-Cancer-Cancer-Cancer-

Gemcitabine and others were nucleosides (like NM-283) idenix's first "drug; ...wait their first drug they marketed and manufactured was Tyzeka together with Novartis . Yes, THEY DID THE MANUFACTURING FOR NOVARTIS!!!. both companies didn't care too much about this drug once they realized that gileads was much better, they were looking forward to NM-283 the first Oral for HCV (I'm dating myself) well, do you know why it didn't work. Like so many oncology drugs....... Toxicity (yup - you needed grams not Micrograms) Then came Sofosbuvir...from Idenix's sister (and I mean sister company) well, the rest is history (no, not really) You think its all about SOF? its not!!! its about the next 20 SOF's in ONCOLOGY!!!
 






Anonymous said:
Quote:
Originally Posted by Anonymous View Post
"Idenix remains focused on the discovery and development of nucleotides and continues its program to identify new compounds and evaluate multiple candidates for development from this discovery program. The nucleoside discovery capability can also be applied to other therapeutic areas outside of HCV, and the Company looks forward to exploring new indications."


Cancer-Cancer-Cancer-Cancer-Cancer-

Gemcitabine and others were nucleosides (like NM-283) idenix's first "drug; ...wait their first drug they marketed and manufactured was Tyzeka together with Novartis . Yes, THEY DID THE MANUFACTURING FOR NOVARTIS!!!. both companies didn't care too much about this drug once they realized that gileads was much better, they were looking forward to NM-283 the first Oral for HCV (I'm dating myself) well, do you know why it didn't work. Like so many oncology drugs....... Toxicity (yup - you needed grams not Micrograms) Then came Sofosbuvir...from Idenix's sister (and I mean sister company) well, the rest is history (no, not really) You think its all about SOF? its not!!! its about the next 20 SOF's in ONCOLOGY!!!
Click to expand...

I get it 'side" vs "tide"
 






Top Bottom
Back
Quote